Hydrochlorothiazide + potassium: Clinical Trials

1 trial of Hydrochlorothiazide + potassium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Hydrochlorothiazide + potassium: new trials by email Literature Review of Hydrochlorothiazide + potassium trials Research Report on Hydrochlorothiazide + potassium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
Spironolactone, Hydrochlorothiazide + potassium, Placebo - Type 2 Diabetes Mellitus, Vascular Disease
Not applicableCompletedBrigham and Women's Hospital692008-09-012017-06-14

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Vascular Diseases (1)

Sponsors

Brigham and Women's Hospital (1)

Countries

United States (1)

Top investigators

Gail K Adler, MD, PhD (1)

Results publications

PMID 25125488, PMID 30409780

NIH funding

R01HL087060 (1)